Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Seattle Biotech -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (47)	5/27/2003 12:03:12 AM
From: keokalani'nui	Read Replies (1) \| Respond to of 70

PSBJ reports amgen will locate its oncology research division up here in a portion of imnx's space it was ready to abandon. Great news! Thousand Oaks was never the place for first tier cancer co, and Seattle deserves one.

To: Mike McFarland who wrote (47)	8/4/2003 3:57:24 AM
From: Mike McFarland	Respond to of 70

Nothing of substance to report, just fun to watch how they unfold these things... seattletimes.nwsource.com (ISB) The institute recently signed a deal with big-name venture capitalists who want first dibs on its technologies. In return, the institute will get founding shares in startups with the potential to boost its endowment. versantventures.com From Private Equity Week 5/23 Accelerator Corp. has been formed by a $15 million investment from MPM Capital, ARCH Venture Partners, Versant Ventures, Alexandria Real Estate Equities Inc. and the Institute for Systems Biology (ISB). The Seattle-based collaborative effort will identify, finance and develop life sciences-related ideas and technologies that either emerge from ISB or, if developed elsewhere, would benefit from affiliation with the ISB's faculty, staff, infrastructure and core facilities. Ah, this is the best link right off the ISB site: systemsbiology.org